Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personality Disorder in Germany

NARecruitingINTERVENTIONAL
Enrollment

304

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

March 31, 2028

Conditions
Borderline Personality Disorder
Interventions
BEHAVIORAL

Mentalization-Based Treatment (MBT)

Patients in MBT will receive a maximum of 58 sessions in total. Of those, 30 are weekly individual sessions. 28 sessions are weekly group sessions conducted by two therapists, and consisting of 8 introductory sessions of group psychoeducation followed by 20 group therapy sessions. The duration of MBT is 12 months. MBT is manualized and relies on validating the emotional experience of patients that aims to promote mentalizing. The proposed mechanism of change in MBT is to stabilize mentalizing in certain focus areas in order to create a psychic buffer between affect and behaviour to foster affect regulation, reduce impulsivity and promote functional supportive relationships.

BEHAVIORAL

Bona-Fide Treatment in Germany (BFT)

Patients in BFT will receive one to two weekly sessions of Bona-Fide-Treatment (Psychodynamic Therapy, PT, or Cognitive Behavioural Therapy, CBT) conducted by community experts delivered as short-term psychotherapy (\<24 sessions) or long-term psychotherapy (\>24 sessions). BFT can be delivered as individual, group or a combination of individual and group treatment as stated in the German psychotherapy regulations.

Trial Locations (5)

69115

RECRUITING

Heidelberg University, Heidelberg

Unknown

RECRUITING

Psychologische Hochschule Berlin, Berlin

NOT_YET_RECRUITING

Clinic for Psychosomatic Medicine and Psychotherapy, University Hospital Düsseldorf, Düsseldorf

NOT_YET_RECRUITING

Institute for Psychosocial Medicine, Psychotherapy and Psychooncology, Jena

NOT_YET_RECRUITING

Clinic for Psychosomatic Medicine and Psychotherapy, University Hospital Ulm, Ulm

Sponsors
All Listed Sponsors
collaborator

German Research Foundation

OTHER

collaborator

University Düsseldorf

OTHER

collaborator

Jena University Hospital

OTHER

collaborator

Universitätsklinikum Ulm

UNKNOWN

collaborator

Psychologische Hochschule Berlin

UNKNOWN

lead

Heidelberg University

OTHER